103 related articles for article (PubMed ID: 34596441)
1.
Cancer Biother Radiopharm; 2021 Oct; 36(8):709. PubMed ID: 34596441
[No Abstract] [Full Text] [Related]
2.
Kong F; Yan Y; Deng J; Zhu Y; Li Y; Li H; Wang Y
Cancer Biother Radiopharm; 2020 Dec; 35(10):e814-e825. PubMed ID: 32716637
[No Abstract] [Full Text] [Related]
3. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
Wang X; Hu K; Chao Y; Wang L
Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ST8SIA6-AS1 promotes colorectal cancer cell proliferation, migration and invasion by regulating the miR-5195/PCBP2 axis.
Huang CM; Cao GY; Yang CX; Chen Y; Liu GD; Xu BW; Zhang X
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4203-4211. PubMed ID: 32373956
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG16 drives proliferation, migration, and invasion of lung cancer cell through modulation of miR-520/VEGF axis.
Chen L; Qiu CH; Chen Y; Wang Y; Zhao JJ; Zhang M
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9522-9531. PubMed ID: 33015794
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression.
Chen H; Li M; Huang P
J Cancer; 2019; 10(15):3571-3581. PubMed ID: 31293662
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
Yu L; Chen D; Song J
Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG16 promotes proliferation and migration in laryngeal squamous cell carcinoma via the miR-140-5p/NFAT5/Wnt/β-catenin pathway axis.
Wan L; Gu D; Li P
Pathol Res Pract; 2022 Jan; 229():153727. PubMed ID: 34911016
[TBL] [Abstract][Full Text] [Related]
9.
Cancer Biother Radiopharm; 2020 Oct; 35(8):628. PubMed ID: 33064575
[No Abstract] [Full Text] [Related]
10. LncRNA SNHG16 induces the SREBP2 to promote lipogenesis and enhance the progression of pancreatic cancer.
Yu Y; Dong JT; He B; Zou YF; Li XS; Xi CH; Yu Y
Future Oncol; 2019 Nov; 15(33):3831-3844. PubMed ID: 31664866
[No Abstract] [Full Text] [Related]
11. LncRNA SNHG16 Promotes the Progression of Laryngeal Squamous Cell Carcinoma by Mediating miR-877-5p/FOXP4 Axis.
Wang X; Liu L; Zhao W; Li Q; Wang G; Li H
Onco Targets Ther; 2020; 13():4569-4579. PubMed ID: 32547087
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG16 contributes to glioma malignancy by competitively binding miR-20a-5p with E2F1.
Yang BY; Meng Q; Sun Y; Gao L; Yang JX
J Biol Regul Homeost Agents; 2018; 32(2):251-261. PubMed ID: 29685003
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG16 accelerates atherosclerosis and promotes ox-LDL-induced VSMC growth via the miRNA-22-3p/HMGB2 axis.
Wang Y; Yang Y; Zhang T; Jia S; Ma X; Zhang M; Wang L; Ma A
Eur J Pharmacol; 2022 Jan; 915():174601. PubMed ID: 34699756
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SNHG16 Functions as an Oncogene by Sponging MiR-4518 and Up-Regulating PRMT5 Expression in Glioma.
Lu YF; Cai XL; Li ZZ; Lv J; Xiang YA; Chen JJ; Chen WJ; Sun WY; Liu XM; Chen JB
Cell Physiol Biochem; 2018; 45(5):1975-1985. PubMed ID: 29529599
[TBL] [Abstract][Full Text] [Related]
15. Silencing of LncRNA SNHG16 Downregulates Cyclin D1 (CCND1) to Abrogate Malignant Phenotypes in Oral Squamous Cell Carcinoma (OSCC) Through Upregulating miR-17-5p.
Wang Q; Han J; Xu P; Jian X; Huang X; Liu D
Cancer Manag Res; 2021; 13():1831-1841. PubMed ID: 33654431
[TBL] [Abstract][Full Text] [Related]
16. SNHG16 promotes tumorigenesis and cisplatin resistance by regulating miR-338-3p/PLK4 pathway in neuroblastoma cells.
Xu Z; Sun Y; Wang D; Sun H; Liu X
Cancer Cell Int; 2020; 20():236. PubMed ID: 32536824
[TBL] [Abstract][Full Text] [Related]
17. lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway.
Zhou XY; Liu H; Ding ZB; Xi HP; Wang GW
Genomics; 2020 Jan; 112(1):1021-1029. PubMed ID: 31226483
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG16 Facilitates Nasopharyngeal Carcinoma Progression by Acting as ceRNA to Sponge miR-520a-3p and Upregulate MAPK1 Expression.
Wu Q; Zhao Y; Shi R; Wang T
Cancer Manag Res; 2021; 13():4103-4114. PubMed ID: 34045897
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG16 contributes to the development of bladder cancer via regulating miR-98/STAT3/Wnt/β-catenin pathway axis.
Feng F; Chen A; Huang J; Xia Q; Chen Y; Jin X
J Cell Biochem; 2018 Nov; 119(11):9408-9418. PubMed ID: 30132983
[TBL] [Abstract][Full Text] [Related]
20. The SNHG16/miR-30a axis promotes breast cancer cell proliferation and invasion by regulating RRM2.
Du SM
Neoplasma; 2020 May; 67(3):567-575. PubMed ID: 32122142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
